VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration

VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration

Purpose: Controversy exists regarding the systemic safety of intravitreal VEGF inhibitors in the treatment of neovascular age-related macular degeneration (nAMD). We aimed to investigate the potential impact of VEGF inhibitor treatment on the risk of all-cause mortality and cardiovascular disease (C...

Full description

Bibliographic Details
Main Authors: Benjamin Sommer Thinggaard, MD, Katrine Frederiksen, MD, PhD, Yousif Subhi, MD, PhD, Sören Möller, PhD, Torben Lykke Sørensen, MD, DMSc, Ryo Kawasaki, MPH, PhD, Jakob Grauslund, MD, PhD, DMSc, Lonny Stokholm, PhD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Ophthalmology Science
Subjects:
Cardiovascular disease
Mortality
Neovascular age-related macular degeneration
Vascular endothelial growth factor inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914523001781

Internet

http://www.sciencedirect.com/science/article/pii/S2666914523001781

Similar Items